Industry Analysis & Industry Trends
The Pharmaceutical Product Manufacturing industry is dominated by major global pharmaceutical groups, although only a small number are engaged in the manufacture of active pharmaceutical ingredients in Australia. An increasing number of firms are limiting their local activities to the later stages of the manufacturing process, including dispensing, packaging and the fill-and-finish stage. A large number of global manufacturers also restrict their Australian activities to distribution.
As with operators in the global pharmaceutical industry, domestic players are currently contending with the effects of the patent cliff... purchase to read more
Industry Report - Industry Key Buyers Chapter
Industry concentration measures the extent to which a few operators dominate an industry. Over the past two decades there has been a marked increase in the level of concentration in the global pharmaceutical industry, as major players have continued to merge, driven by escalating R&D costs, shorter exclusivity times and the need for global marketing power. The number of major players is expected to continue its downward trend over the next five years, especially as players continue to lose market share in the new post-blockbuster era. In contrast, smaller specialty and biotech pharmaceutical players are expected to gain ground, boosted by the emergence of new biotech-based blockbuster drugs... purchase to read more